Predicting Lymphovascular Invasion in Non-small Cell Lung Cancer Using Deep Convolutional Neural Networks on
Jian Wang1, Yang Yang2, Zongyu Xie2
1Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China; Department of Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.
Rationale And Objectives:
Lymphovascular invasion (LVI) plays a significant role in precise treatments of non-small cell lung cancer (NSCLC). This study aims to build a non-invasive LVI prediction diagnosis model by combining preoperative CT images with deep learning technology.
Materials And Methods:
This retrospective observational study included a series of consecutive patients who underwent surgical resection for non-small cell lung cancer (NSCLC) and received pathologically confirmed diagnoses. The cohort was randomly divided into a training group comprising 70 % of the patients and a validation group comprising the remaining 30 %. Four distinct deep convolutional neural network (DCNN) prediction models were developed, incorporating different combination of two-dimensional (2D) and three-dimensional (3D) CT imaging features as well as clinical-radiological data. The predictive capabilities of the models were evaluated by receiver operating characteristic curves (AUC) values and confusion matrices. The Delong test was utilized to compare the predictive performance among the different models.
Results:
A total of 3034 patients with NSCLC were recruited in this study including 106 LVI+ patients. In the validation cohort, the Dual-head Res2Net_3D23F model achieved the highest AUC of 0.869, closely followed by the models of Dual-head Res2Net_3D3F (AUC, 0.868), Dual-head Res2Net_3D (AUC, 0.867), and EfficientNet-B0_2D (AUC, 0.857). There was no significant difference observed in the performance of the EfficientNet-B0_2D model when compared to the Dual-head Res2Net_3D3F and Dual-head Res2Net_3D23F.
Conclusion:
Findings of this study suggest that utilizing deep convolutional neural network is a feasible approach for predicting pathological LVI in patients with NSCLC.
